KITEMergers•businesswire•
Kite to Acquire Interius BioTherapeutics to Advance In Vivo Platform
Sentiment:Neutral (60)
Summary
SANTA MONICA, Calif. & PHILADELPHIA--(BUSINESS WIRE)--Kite has entered into a definitive agreement to acquire Interius BioTherapeutics, a privately held company developing in vivo CAR therapeutics.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 21, 2025 by businesswire